DrugPatentWatch Database Preview
Bristol Myers Squibb Company Profile
What is the competitive landscape for BRISTOL MYERS SQUIBB, and when can generic versions of BRISTOL MYERS SQUIBB drugs launch?
BRISTOL MYERS SQUIBB has seventy-five approved drugs.
There are seventeen US patents protecting BRISTOL MYERS SQUIBB drugs.
There are four hundred and forty-seven patent family members on BRISTOL MYERS SQUIBB drugs in fifty-seven countries and one hundred and eighty-two supplementary protection certificates in fifteen countries.
Summary for Bristol Myers Squibb
International Patents: | 447 |
US Patents: | 17 |
Tradenames: | 65 |
Ingredients: | 57 |
NDAs: | 75 |
Patent Litigation for Bristol Myers Squibb: | See patent lawsuits for Bristol Myers Squibb |
Drugs and US Patents for Bristol Myers Squibb
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | PROTAMINE ZINC INSULIN | insulin susp protamine zinc purified beef | INJECTABLE;INJECTION | 017928-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
Bristol Myers Squibb | SPRYCEL | dasatinib | TABLET;ORAL | 021986-001 | Jun 28, 2006 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
Bristol Myers Squibb | ETOPOPHOS PRESERVATIVE FREE | etoposide phosphate | INJECTABLE;INJECTION | 020906-002 | Feb 27, 1998 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
Bristol Myers Squibb | VIDEX | didanosine | TABLET, CHEWABLE;ORAL | 020154-005 | Oct 9, 1991 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
Bristol Myers Squibb | OXYCODONE 2.5/APAP 500 | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 085910-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Bristol Myers Squibb
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | VIDEX | didanosine | FOR SOLUTION;ORAL | 020155-004 | Oct 9, 1991 | 5,254,539*PED | ➤ Try a Free Trial |
Bristol Myers Squibb | VIDEX | didanosine | TABLET, CHEWABLE;ORAL | 020154-004 | Oct 9, 1991 | 5,880,106*PED | ➤ Try a Free Trial |
Bristol Myers Squibb | SERZONE | nefazodone hydrochloride | TABLET;ORAL | 020152-001 | Dec 22, 1994 | 5,256,664*PED | ➤ Try a Free Trial |
Bristol Myers Squibb | PRAVIGARD PAC (COPACKAGED) | aspirin; pravastatin sodium | TABLET, TABLET, TABLET;ORAL | 021387-002 | Jun 24, 2003 | 4,346,227*PED | ➤ Try a Free Trial |
Bristol Myers Squibb | PRAVACHOL | pravastatin sodium | TABLET;ORAL | 019898-002 | Oct 31, 1991 | 5,180,589*PED | ➤ Try a Free Trial |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for BRISTOL MYERS SQUIBB drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 100 mg and 150 mg | ➤ Subscribe | 2010-03-19 |
➤ Subscribe | Tablets | 600 mg | ➤ Subscribe | 2009-04-09 |
➤ Subscribe | Nasal Spray | 4 mg/spray | ➤ Subscribe | 2016-07-15 |
➤ Subscribe | Tablets | 2.5 mg and 5 mg | ➤ Subscribe | 2016-12-28 |
➤ Subscribe | Tablets | 20 mg, 50 mg, 70 mg and 100 mg | ➤ Subscribe | 2010-06-28 |
➤ Subscribe | Tablets | 80 mg and 140 mg | ➤ Subscribe | 2011-06-17 |
➤ Subscribe | Capsules | 300 mg | ➤ Subscribe | 2009-07-20 |
➤ Subscribe | Capsules | 200 mg | ➤ Subscribe | 2010-02-16 |
➤ Subscribe | Capsules | 50 mg, 100 mg and 200 mg | ➤ Subscribe | 2016-11-03 |
➤ Subscribe | Tablets | 0.5 mg and 1 mg | ➤ Subscribe | 2010-06-14 |
➤ Subscribe | Tablets | 30 mg | ➤ Subscribe | 2005-06-01 |
➤ Subscribe | Tablets | 80 mg and 140 mg | ➤ Subscribe | 2011-06-16 |
➤ Subscribe | Delayed-release Capsules | 200 mg, 250 mg and 400 mg | ➤ Subscribe | 2004-06-01 |
International Patents for Bristol Myers Squibb Drugs
Country | Document Number | Estimated Expiration |
---|---|---|
Japan | 3418626 | ➤ Try a Free Trial |
China | 1980909 | ➤ Try a Free Trial |
Singapore | 10201501349V | ➤ Try a Free Trial |
Norway | 322470 | ➤ Try a Free Trial |
Australia | 2005304863 | ➤ Try a Free Trial |
Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Bristol Myers Squibb Drugs
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
2013 00006 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: DASATINIB OG FARMACEUTISK ACCEPTABLE SALTE DERAF, HERUNDER MONOHYDRATET; REG. NO/DATE: EU/1/06/363/001-015 20061122 |
0596 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: INSULINE DEGLUDEC; NATIONAL REGISTRATION NO/DATE: EU/1/12/807/004 20130123; FIRST REGISTRATION: EU EU/1/12/807/001 20130123 |
2015000093 | Germany | ➤ Try a Free Trial | PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129 |
/2000 | Austria | ➤ Try a Free Trial | PRODUCT NAME: INSULIN ASPART/PROTAMIN; NAT. REGISTRATION NO/DATE: EU/1/00/142/001-008 20000801; FIRST REGISTRATION: LI 55414-55416 20000623 |
C0044 | Belgium | ➤ Try a Free Trial | PRODUCT NAME: INSULIN-ASPART; NAT. REGISTRATION NO/DATE: EU/1/99/119/001 19990907; FIRST REGISTRATION: CH 55045 01 19990615 |
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.